SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
OMEROS
(NQNM:OMER Last Sale: 16.72 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (OMER : $16.72)
$906,311 million Market Cap at Market Close, July 1, 2022
Employs 67.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
1420 Fifth Avenue Research Report Earnings Snapshot - Last 11/10/18
Seattle, WA Fact Sheet
Phone: 206-676-5000 Financial Statements
Peer Comparison
Annual Reports

Gregory A. Demopulos, Co-Founder/CEO/Pres., Pamela P. Palmer, Co-Founder
Focused on inflammation and disorders of the central nervous system. Controversy with former CFO, whistleblower regarding NIH confilcts of interest and possible research improprieties. IPO at $10 October 6, 2009. Raised $68.2 million, selling 6.8 million shares, 32% of the outstanding. Lead Manager: Deutsche Bank.
Historical Charts    Technical Analysis
No Historical Data available for OMER

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common OMER $16.72 $16.72 0 .0 $15.63 $16.81 418,173 $15.63 $16.81 54,205,177
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $906,310,559

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex